Page last updated: 2024-12-07

1-amino-1-phenylmethyl phosphonic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-amino-1-phenylmethyl phosphonic acid : A member of the class of phosphonic acids that is phosphonic acid having a amino(phenyl)methyl group attached to the phosphorus. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID98449
CHEMBL ID1090366
CHEBI ID86535
SCHEMBL ID233491

Synonyms (36)

Synonym
18108-22-0
nsc133874
nsc-133874
nsc-669595
nsc 133874
phosphonic acid, (alpha-aminobenzyl)- (6ci,8ci)
(alpha-aminobenzyl)phosphonic acid
brn 2049498
(aminophenylmethyl)phosphonic acid
OPREA1_794855
nsc669595
phosphonic acid, (aminophenylmethyl)-
[amino(phenyl)methyl]phosphonic acid
BMSE000171
chebi:86535 ,
amino(phenyl)methylphosphonic acid
CHEMBL1090366 ,
bdbm50316031
AKOS001016495
4-07-00-00555 (beilstein handbook reference)
phosphonic acid, (alpha-aminobenzyl)-
37714-05-9
AKOS017344475
SCHEMBL233491
melengestrolacetate
1-amino-1-phenylmethyl phosphonic acid
(r)-1-phosphono-benzylamine
a-aminobenzylphosphonic acid
(amino(phenyl)methyl)phosphonic acid
Q27159222
CS-0269760
phosphonic acid, p-(aminophenylmethyl)-
(1-amino-1-phenylmethyl)phosphonic acid
DTXSID501305747
Z55625577
EN300-7832206
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
benzenesAny benzenoid aromatic compound consisting of the benzene skeleton and its substituted derivatives.
phosphonic acidsHP(=O)(OH)2 (phosphonic acid) and its P-substituted derivatives.
primary amino compoundA compound formally derived from ammonia by replacing one hydrogen atom by an organyl group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Aminopeptidase NSus scrofa (pig)IC50 (µMol)220.00000.00053.53548.9000AID472434
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (6)

Processvia Protein(s)Taxonomy
regulation of translationMethionine aminopeptidase 1Homo sapiens (human)
proteolysisMethionine aminopeptidase 1Homo sapiens (human)
peptidyl-methionine modificationMethionine aminopeptidase 1Homo sapiens (human)
N-terminal protein amino acid modificationMethionine aminopeptidase 1Homo sapiens (human)
protein maturationMethionine aminopeptidase 1Homo sapiens (human)
platelet aggregationMethionine aminopeptidase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (6)

Processvia Protein(s)Taxonomy
aminopeptidase activityMethionine aminopeptidase 1Homo sapiens (human)
initiator methionyl aminopeptidase activityMethionine aminopeptidase 1Homo sapiens (human)
protein bindingMethionine aminopeptidase 1Homo sapiens (human)
metalloexopeptidase activityMethionine aminopeptidase 1Homo sapiens (human)
metal ion bindingMethionine aminopeptidase 1Homo sapiens (human)
metalloaminopeptidase activityMethionine aminopeptidase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (3)

Processvia Protein(s)Taxonomy
cytoplasmMethionine aminopeptidase 1Homo sapiens (human)
cytosolMethionine aminopeptidase 1Homo sapiens (human)
cytosolic ribosomeMethionine aminopeptidase 1Homo sapiens (human)
cytosolMethionine aminopeptidase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (12)

Assay IDTitleYearJournalArticle
AID1091063Inhibition of Arabidopsis thaliana P5C assessed as reduction in NADH oxidation incubated at 35 degC up to 10 min2008Journal of agricultural and food chemistry, May-14, Volume: 56, Issue:9
Tailoring the structure of aminobisphosphonates to target plant P5C reductase.
AID513949Effect on human cytoplasmic protein tyrosine phosphatase B assessed as change in enzyme activity at 100 uM at pH 52010Bioorganic & medicinal chemistry, Jul-15, Volume: 18, Issue:14
Identification of novel inhibitors for a low molecular weight protein tyrosine phosphatase via virtual screening.
AID513947Effect on human cytoplasmic protein tyrosine phosphatase A assessed as change in enzyme activity at 100 uM at pH 52010Bioorganic & medicinal chemistry, Jul-15, Volume: 18, Issue:14
Identification of novel inhibitors for a low molecular weight protein tyrosine phosphatase via virtual screening.
AID513948Effect on human cytoplasmic protein tyrosine phosphatase A assessed as change in enzyme activity at 100 uM at pH 72010Bioorganic & medicinal chemistry, Jul-15, Volume: 18, Issue:14
Identification of novel inhibitors for a low molecular weight protein tyrosine phosphatase via virtual screening.
AID1111047Inhibition of Zea mays cv. Jeff (maize) leaf glutamine synthetase using L-glutamate as substrate assessed as inorganic phosphate production at 1 mM after 20 min by malachite green assay relative to control2010Pest management science, Jan, Volume: 66, Issue:1
Effectiveness and mode of action of phosphonate inhibitors of plant glutamine synthetase.
AID1200778Inhibition of human MetAP1b F309M mutant using Met-pNA as substrate2015Journal of medicinal chemistry, Mar-12, Volume: 58, Issue:5
Identification of the molecular basis of inhibitor selectivity between the human and streptococcal type I methionine aminopeptidases.
AID1200777Inhibition of Streptococcus pneumoniae MetAP1a using Met-pNA as substrate2015Journal of medicinal chemistry, Mar-12, Volume: 58, Issue:5
Identification of the molecular basis of inhibitor selectivity between the human and streptococcal type I methionine aminopeptidases.
AID1111046Inhibition of Zea mays cv. Jeff (maize) leaf glutamine synthetase using L-glutamate as substrate assessed as inorganic phosphate production after 20 min by malachite green assay relative to control2010Pest management science, Jan, Volume: 66, Issue:1
Effectiveness and mode of action of phosphonate inhibitors of plant glutamine synthetase.
AID1200776Inhibition of Human MetAP1b using Met-pNA as substrate2015Journal of medicinal chemistry, Mar-12, Volume: 58, Issue:5
Identification of the molecular basis of inhibitor selectivity between the human and streptococcal type I methionine aminopeptidases.
AID1200780Inhibition of Enterococcus faecalis MetAP1a using Met-pNA as substrate2015Journal of medicinal chemistry, Mar-12, Volume: 58, Issue:5
Identification of the molecular basis of inhibitor selectivity between the human and streptococcal type I methionine aminopeptidases.
AID1200779Inhibition of Mycobacterium tuberculosis MetAP1c using Met-pNA as substrate2015Journal of medicinal chemistry, Mar-12, Volume: 58, Issue:5
Identification of the molecular basis of inhibitor selectivity between the human and streptococcal type I methionine aminopeptidases.
AID472434Inhibition of pig kidney aminopeptidase N using Leu-AMC as substrate2010Bioorganic & medicinal chemistry, Apr-15, Volume: 18, Issue:8
New aromatic monoesters of alpha-aminoaralkylphosphonic acids as inhibitors of aminopeptidase N/CD13.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.50

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.50 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.30 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.50)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]